Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (18)
  • Antithrombotics (289)
    • Drug-Induced Thrombosis (28)
    • Prevention (44)
    • Reversal (22)
    • Treatment (264)
      • Apixaban (Eliquis) (100)
      • Aspirin (136)
      • Cangrelor (Kengreal) (4)
      • Clopidogrel (Plavix) (80)
      • Dabigatran (Pradaxa) (101)
      • Edoxaban (Savaysa) (41)
      • Low Molecular Weight Heparins (63)
      • Other (40)
      • Prasugrel (Effient) (42)
      • Rivaroxaban (Xarelto) (110)
      • Ticagrelor (Brilinta) (40)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (29)
      • Warfarin - Treatment (120)
  • Arrhythmias (131)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (23)
  • CPR (6)
  • Dyslipidemia (168)
  • Endocarditis (21)
  • Heart Disease (84)
  • Heart Failure (155)
  • Hypertension (225)
  • Hypotension (27)
  • Ischemic Heart Disease/Acute Coronary Syndromes (244)
  • Myocardial Infarction (48)
  • Peripheral Vascular Disease (8)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (699)
  • Stroke (119)
136 - 150 of 264 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Safety of Long-Term Treatment with Clopidogrel (Plavix) January 2016
Article: Add Idarucizumab To Your DOAC Reversal Protocol for Dabigatran December 2015
Article: Implement a Therapeutic Interchange for Durlaza to Low-Dose Aspirin December 2015
PL Voices: Praxbind (idarucizumab) to Reverse Bleeding with Pradaxa (dabigatran) December 2015
Commentary: New Formulation: Durlaza (Aspirin Extended-Release) December 2015
Article: Use a Checklist to Help Patients Safely Take DOACs October 2015
Article: Watch for Hypoglycemia in Patients Taking Repaglinide Plus Clopidogrel October 2015
Checklist: Monitoring Checklist for the New Oral Anticoagulants October 2015
Commentary: New Drug: Kengreal (Cangrelor) October 2015
PL Voices: Monitoring Direct Oral Anticoagulants October 2015
Commentary: Oral Anticoagulants: Maximizing Safety October 2015
Article: Limit the Aspirin Dose to 81 mg in Stroke Patients September 2015
Article: Verify ICH Patients Get VTE Prophylaxis September 2015
Article: Expect More Bleeding When Cangrelor Is Used September 2015
Guideline: American Heart Association/American Stroke Association Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) September 2015
  • « Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved